DSN recently talked with COPD Foundation founder and president John Walsh about the organization's new leadership. In March, the COPD Foundation took over leadership for Drive4COPD, which aims to screen people for chronic obstructive pulmonary disease, a collective term for emphysema and chronic bronchitis, which the group estimates to affect 24 million Americans who may have it but don't know it.
Earlier this month, Walgreens announced that immunization records would be sent directly from its more than 7,800 Walgreens and Duane Reade stores and 350 Take Care Clinics to primary care providers over Surescripts’ electronic prescribing network using Surescripts’ Clinical Interoperability services. And later this year, the company plans to share immunization data with local and state public health agencies, and share Take Care Clinic patient summaries with primary care providers. Drug Store News recently had the opportunity to speak with Surescripts president and CEO Harry Totonis about the new service.
Radio Health Journal's Reed Pence talks with DSN editor in chief Rob Eder; Walgreens president of pharmacy, health and wellness Kermit Crawford; Express Scripts senior director of public affairs Brian Henry; and former Walgreens pharmacy customer Virginia Greathouse about the causes and impact of the Walgreens-ESI dispute.
As of Jan. 1, asthma products like the Primatine Mist inhaler became no longer available at retail — leaving consumers with few asthma-care options in the OTC aisle. Drug Store News recently interviewed King Bio president Frank King, who is introducing a new nonprescription inhaler for asthmatics, formulated with homeopathic ingredients, called AsthmaCare under its Safecare banner of products.
The National Association of Chain Drug Stores commented on the proposed regulations on the use of managed care in Medicaid and in the Children’s Health Insurance Program, urging "to maintain the strong link between Medicaid patients and community pharmacies and the valuable services that these pharmacies provide."
In late July, the Government Accountability Office released a report on how the lack of effective communications between the Drug Enforcement Agency and both pharmaceutical distributors and chain pharmacy headquarters has impacted legitimate access to pain medicines. "The agency’s report further validates the need for bipartisan, bicameral legislation," according to NACDS.
Hair care brand Alberto VO5 on Thursday declared August its third annual “National Anti-Frizz Month,” offering frizz-taming advice and savings on frizz products via the brand’s website and social media channels.
The Consumer Healthcare Products Association expressed support for the DXM Abuse Prevention Act, introduced into the U.S. House of Representatives by U.S. Reps. Bill Johnson, R-Ohio, and Doris Matsui, D-Calif., on Wednesday.
The DEA announced on Tuesday that the 10th National Prescription Drug Take-Back will take place across the United States on Sept. 26 — except for in Pennsylvania and Delaware where the event will take place on Sept. 12.
Voters from all political parties support sunshine legislation that would make promote transparency in generic prescription drug payments by pharmacy benefit manager corporations, according to a national survey from the National Community Pharmacists Association released Tuesday.
Sandoz on Tuesday announced the launch of a generic version of AstraZeneca’s Pulmicort Respules (budesonide inhalation suspension) in 1-mg strength. Sandoz expects to have 180-day generic drug marketing exclusivity for the 1-mg strength.